Literature DB >> 268640

Tumor promoters inhibit spontaneous differentiation of Friend erythroleukemia cells in culture.

G Rovera, T G O'Brien, L Diamond.   

Abstract

Clones of Friend erythroleukemia cells, characterized by the presence of 40-70% benzidine-positive cells synthesizing hemoglobin in the absence of inducing drugs, were treated with several phorbol diesters with a known range of tumor-promoting activity on mouse skin. Good correlation was found between the reported tumor-promoting activity of a particular phorbol diester and its ability to inhibit spontaneous erythroid differentiation in culture. The inhibition of differentiation by 12-O-tetradecanoyl-phorbol-13-acetate, the most active tumor promoter, was maximum after 4 days of treatment; this inhibition was reversed by removal of the phorbol diester no matter how long the period of treatment. Unlike control cells, which gradually revert to a population with a low percentage of benzidine-positive cells, cells treated with 12-O-tetradecanoyl-phorbol-13-acetate retained a high potential for spontaneous differentiation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 268640      PMCID: PMC431336          DOI: 10.1073/pnas.74.7.2894

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Differentiation in erythroleukemic cells and their somatic hybrids.

Authors:  S H Orkin; F I Harosi; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  A cell culture system for the assessment of tumor-promoting activity.

Authors:  A Sivak; B L Van Duuren
Journal:  J Natl Cancer Inst       Date:  1970-05       Impact factor: 13.506

Review 4.  Studies on the control of differentiation of murine virus-induced erythroleukemic cells.

Authors:  C Friend; H D Preisler; W Scher
Journal:  Curr Top Dev Biol       Date:  1974       Impact factor: 4.897

Review 5.  Tumor-promoting agents in two-stage carcinogenesis.

Authors:  B L Van Duuren
Journal:  Prog Exp Tumor Res       Date:  1969

6.  Growth stimulation of human diploid fibro-blasts by the tumor promoter, 12-0-tetradecanoly-phorbol-13-acetate.

Authors:  L Diamond; S O'Brien; C Donaldson; Y Shimizu
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

7.  Effect of a tumour promoter on myogenesis.

Authors:  R Cohen; M Pacifici; N Rubinstein; J Biehl; H Holtzer
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

8.  Synthesis of erythrocyte-specific proteins in cultured friend leukemia cells.

Authors:  D Kabat; C C Sherton; L H Evans; R Bigley; R D Koler
Journal:  Cell       Date:  1975-07       Impact factor: 41.582

9.  Effect of phorbol myristate acetate on the recovery of spontaneous and ultraviolet light-induced 6-thioguanine and ouabain-resistant Chinese hamster cells.

Authors:  J E Trosko; C C Chang; L P Yotti; E H Chu
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

10.  The phenotypes of variant clones of Friend mouse erythroleukemic cells resistant to dimethyl sulfoxide.

Authors:  G Rovera; J Bonaiuto
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

View more
  44 in total

1.  Catabolism of 2-deoxyglucose by phagocytic leukocytes in the presence of 12-O-tetradecanoyl phorbol-13-acetate.

Authors:  P Zabos; D Kyner; N Mendelsohn; C Schreiber; S Waxman; J Christman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

2.  Sialyltransferase activity as a marker for the differentiation of lymphocytes. Increase in sialyltransferase activity of blasts from acute lymphoblastic leukaemia cases by 12-o-tetradecanoylphorbol-13-acetate (TPA).

Authors:  R Sasaki; F Takaku; Y L Lin; F J Bollum
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

3.  Opposing effects of interferon produced in bacteria and of tumor promoters on myogenesis in human myoblast cultures.

Authors:  P B Fisher; A F Miranda; L E Babiss; S Pestka; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

4.  Continuous suppression of globin gene expression and differentiation of Friend erythroleukemia cells by phorbol 12-myristate 13-acetate (PMA) despite the loss of PMA binding sites by down regulation.

Authors:  H Yamasaki; N Martel; A Fusco; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Effects of n-butyrate and phorbol ester (TPA) on induction of Epstein-Barr virus antigens and cell differentiation.

Authors:  E Anisimová; K Prachová; J Roubal; V Vonka
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

6.  Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.

Authors:  J Lotem; L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

7.  12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.

Authors:  J A Brieva; J S Louie; R H Stevens
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

8.  Tumor promoter phorbol myristic acetate stimulates immunoglobulin secretion correlated with growth cessation in human B lymphocyte cell lines.

Authors:  P Ralph; T Kishimoto
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

9.  Antagonism between epidermal growth factor and phorbol ester tumor promoters in human breast cancer cells.

Authors:  C K Osborne; B Hamilton; M Nover; J Ziegler
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

10.  Phorbol diester-induced macrophage differentiation of leukemic blasts from patients with human myelogenous leukemia.

Authors:  H P Koeffler; M Bar-Eli; M Territo
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.